Item | Valuea | CoV |
---|---|---|
Amount of injected CA (g) | 32 ± 5 | 16% |
Dose of CA per TBW (gI/kg) | 0.46 ± 0.06 | 13% |
Dose of CA per TBW (gI/kg) according to BMIb | ||
 Underweight (BMI < 18.5 kg/m2) | 0.56 ± 0.08 | 14% |
 Normal weight (18.5 ≤ BMI < 25 kg/m2) | 0.48 ± 0.05 | 10% |
 Overweight (25 ≤ BMI < 30 kg/m2) | 0.44 ± 0.04 | 9% |
 Obese (BMI ≥ 30 kg/m2) | 0.41 ± 0.04 | 10% |
Dose of CA per LBW (gI/kg) | 0.63 ± 0.09 | 14% |
Dose of CA per LBW (gI/kg) according to BMIc | ||
 Underweight (BMI < 18.5 kg/m2) | 0.68 ± 0.11 | 16% |
 Normal weight (18.5 ≤ BMI < 25 kg/m2) | 0.62 ± 0.08 | 13% |
 Overweight (25 ≤ BMI < 30 kg/m2) | 0.62 ± 0.08 | 13% |
 Obese (BMI ≥ 30 kg/m2) | 0.65 ± 0.11 | 17% |
Liver contrast enhancement (HU)d | 43 ± 9 | 21% |
Liver contrast enhancement (HU) according to BMIe | ||
 Underweight (BMI < 18.5 kg/m2) | 51 ± 18 | 35% |
 Normal weight (18.5 ≤ BMI < 25 kg/m2) | 44 ± 8 | 18% |
 Overweight (25 ≤ BMI < 30 kg/m2) | 42 ± 9 | 18% |
 Obese (BMI ≥ 30 kg/m2) | 40 ± 6 | 15% |